KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dillard'S (DDS) EBITDA (2016 - 2026)

Dillard'S's EBITDA history spans 18 years, with the latest figure at $625.5 million for Q1 2026.

  • For Q1 2026, EBITDA rose 35.61% year-over-year to $625.5 million; the TTM value through Jan 2026 reached $2.1 billion, up 9.57%, while the annual FY2026 figure was $145.9 million, 4.77% down from the prior year.
  • EBITDA reached $625.5 million in Q1 2026 per DDS's latest filing, up from $492.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $625.5 million in Q1 2026 to a low of $191.0 million in Q3 2023.
  • Average EBITDA over 5 years is $389.8 million, with a median of $391.9 million recorded in 2024.
  • Peak YoY movement for EBITDA: crashed 54.9% in 2023, then skyrocketed 120.1% in 2024.
  • A 5-year view of EBITDA shows it stood at $269.4 million in 2022, then fell by 20.15% to $215.1 million in 2023, then soared by 120.1% to $473.4 million in 2024, then increased by 4.02% to $492.4 million in 2025, then rose by 27.03% to $625.5 million in 2026.
  • Per Business Quant, the three most recent readings for DDS's EBITDA are $625.5 million (Q1 2026), $492.4 million (Q4 2025), and $412.5 million (Q3 2025).